常染色体显性多囊肾病早期与晚期肾功能储备容量的研究
本研究为横断面研究,纳入300名参与者,通过多巴胺输注测量常染色体显性多囊肾病(ADPKD)患者的肾功能储备容量。结果发现,早期ADPKD患者(eGFR≥60 ml/min per 1.73 m2)的肾功能储备容量与健康对照相似,甚至在最年轻组更高;肾功能储备容量下降与较低的实测GFR相关,提示高滤过可能不是ADPKD的早期现象。
要点
- 早期ADPKD患者保留肾功能储备容量,能对多巴胺反应性增加GFR。
- 肾功能储备容量下降与较低实测GFR相关,而非早期普遍现象。
- 晚期ADPKD患者肾功能储备容量较健康对照降低。
核心结论
- 早期ADPKD患者,无论快速或缓慢进展,均能增加GFR以响应多巴胺。
- 以肾功能储备容量丧失定义的高滤过可能不是ADPKD的早期现象。
研究设计与样本
- 横断面研究,共300名参与者,包括ADPKD患者和年龄性别匹配的潜在肾捐献者作为健康对照。
- 通过连续输注125I-碘酞酸盐测量GFR作为尿液清除率,并输注多巴胺4.4-6 mg/h后测量GFR增加以确定肾功能储备容量。
主要发现
- 最年轻年龄组(18-29岁)中,ADPKD患者与健康对照的实测GFR无差异(103±21 vs 111±9 ml/min per 1.73 m2;P=0.14)。
- 同年龄组中,ADPKD患者肾功能储备容量高于健康对照(11.1%±8.3% vs 5.3%±6.5%;P=0.04)。
- 早期ADPKD患者(eGFR≥60 ml/min per 1.73 m2)肾功能储备容量与健康对照相似,无论整体或按Mayo身高调整总肾脏体积分类的快速或缓慢进展者。
- ADPKD患者中,较低实测GFR与较低肾功能储备容量相关(β=1.0 [95% CI,0.5至1.5] %每10 ml/min per 1.73 m2;P<0.001)。
- 因此,在较大年龄和较晚CKD阶段,肾功能储备容量较健康对照降低。
临床怎么用
- 对于早期ADPKD患者,肾功能储备容量保留,提示高滤过可能不是早期干预的靶点。
- 临床评估ADPKD进展时,需考虑年龄和CKD阶段对肾功能储备容量的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: It is assumed that in autosomal dominant polycystic kidney disease (ADPKD), kidney function remains in the normal range for several decades because of hyperfiltration of remnant nephrons. In this study, we investigate the extent to which patients with ADPKD hyperfilter. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this cross-sectional study, we measured GFR as urinary clearance using continuous infusion of 125I-iothalamate. Kidney function reserve capacity was determined as increase in measured GFR after adding a dopamine infusion of 4.4-6 mg/h. Potential kidney donors were used as healthy controls and matched by age and sex to patients with ADPKD for comparisons across age groups and CKD stages. Hyperfiltration was defined by a loss of kidney function reserve capacity compared with healthy controls. RESULTS: A total of 300 participants were studied. In the youngest age group (18-29 years), measured GFR was not different between patients with ADPKD and healthy controls (103±21 versus 111±9 ml/min per 1.73 m2; P=0.14). In this age group kidney function reserve capacity was higher compared with healthy controls (11.1%±8.3% versus 5.3%±6.5%; P=0.04). Moreover, kidney function reserve capacity was similar to healthy controls in patients with ADPKD with early-stage disease (eGFR≥60 ml/min per 1.73 m2), either overall or when divided into fast or slow progressors according to their Mayo height-adjusted total kidney volume class. However, in patients with ADPKD, lower measured GFR was associated with lower kidney function reserve capacity (β=1.0 [95% confidence interval, 0.5 to 1.5] % per 10 ml/min per 1.73 m2; P<0.001). Kidney function reserve capacity was therefore lower compared with healthy controls at older age and later CKD stages. CONCLUSIONS: Patients with early-stage ADPKD, either classified as having rapidly or slowly progressive disease, are able to increase their GFR in response to dopamine. Hyperfiltration, defined by a loss of kidney function reserve capacity, may therefore not be an early phenomenon in ADPKD.
引用
- Messchendorp AL, van Londen M, Taylor JM, et al. Kidney Function Reserve Capacity in Early and Later Stage Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2018. PMID: 30254028. doi:10.2215/CJN.03650318
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。